Understanding rheumatoid arthritis;Comment comprendre la polyarthrite rhumatoïde?

Revue du Praticien

Volumn 55, Issue 19, 2005, Pages 2134-2142

  Sibilia, Jean ^b   Sordet, Christelle ^b   Mrabet, Dalila ^b   Wachsmann, Dominique ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHEMOKINE; COMPLEMENT; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 6; NITROUS OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; B LYMPHOCYTE; BONE DESTRUCTION; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; ENZYME SYNTHESIS; FIBROBLAST; HUMAN; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MAST CELL; OSTEOCLAST; PATHOGENESIS; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVITIS; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; MACROPHAGE ACTIVATION; MACROPHAGES; NEUTROPHILS; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 29444460833     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
2. Chen T, Rimpilainen M, Luukkainen R, et al. Bacterial components in the synovial tissue of patients with advanced rheumatoid arthritis or osteoarthritis: analysis with gas chromatography-mass spectrometry and pan-bacterial polymerase chain reaction. Arthritis Rheum 2003;49:328-34.
3. van der Heijden IM, Wilbrink B, Tchetverikov I, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000;43:593-8.
4. Erratum in: Arthritis Rheum 2000;43:1061.
5. Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ, Firestein GS. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 2002;99:10025-30.
6. Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation? Ann Rheum Dis 2004;63:1186-94.
7. Ohata J, Zvaifler NJ, Nishio M, et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005;174:864-70.
8. Ritchlin CT. Mechanisms of erosion in rheumatoid arthritis. J Rheumatol 2004;31:1229-37.
9. Seemayer CA, Kuchen S, Kuenzler P, et al. Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 2003;162:1549-57.
10. Pierer M, Rethage J, Seibl R, et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004;172:1256-65.
11. Erratum in: J Immunol 2004;172:following 2703.
12. Goronzy JJ, Weyand CM. T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 2004;16:212-7.
13. Firestein GS. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. J Clin Invest 2004;114:471-4. Review.
14. Erratum in: J Clin Invest 2004;114:1002.
15. Kraan MC, Haringman JJ, Weedon H, et al. T cells, fibroblast-like synoviocytes, and granzyme B + cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63:483-8.
16. Lubberts E, van den Bersselaar L, Oppers-Walgreen B, et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 2003;170:2655-62.
17. Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 1999;90:65-78.
18. Hata N, Sakaguchi N, Yoshitomi H, et al. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 2004;114:582-8.
19. Sakaguchi N, Takahashi T, Hata H, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003;426:454-60.
20. Salmon M, Akbar AN. Telomere erosion: a new link between HLA DR4 and rheumatoid arthritis? Trends Immunol 2004;25:339-41.
21. Schonland SO, Lopez C, Widmann T, et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A 2003;100:13471-6.
22. Martin F, Chan AC. Pathogenic roles of B cells in human autoimmunity: insights from the clinic. Immunity 2004;20:517-27.
23. Kamradt T, Schubert D. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res Ther 2005;7:20-8.
24. Matsumoto I, Maccioni M, Lee DM, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002;3:360-5.
25. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-92.
26. Ji H, Ohmura K, Mahmood U, et al. Arthritis critically dependent on innate immune system players. Immunity 2002;16:157-68.
27. Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004;50:3485-94.
28. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538-41.
29. van Gaalen FA, van Aken J, Huizinga TW, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004;50:2113-21.
30. Svelander L, Erlandsson Harris H, Lorentzen JC, Trollmo C, Klareskog L, Bucht A. Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats. Arthritis Rheum 2004;50:297-304.
31. Kyburz D, Rethaqe J, Seibl R, et al. Bacterial peptidoglycans but not CpG oliqodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 2003;48:642-50.
32. Neff L, Zeisel M, Druet V, et al. ERK1/2 and JNKs-dependent synthesis of interleukins 6 and 8 by fibroblast-like synoviocytes stimulated with protein I/II, a modulin from oral streptococci, reguires focal adhesion kinase. J Biol Chem 2003;278:27721-8.
33. Radstake TR, Franke B, Nanssen S, et al. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 2004;50:999-1001.
34. Constantin A, Dieude P, Lauwers-Cances V, et al. Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis Rheum 2004;50:742-7.